Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content

Wegovy reference

What to do if you miss a Wegovy dose

If within 5 days: take the missed dose as soon as you remember, then resume the regular weekly schedule. More than 5 days late: skip it and inject your next scheduled dose. Never double up.

Detailed guidance

  • Within 5 days of missed dose: take it immediately, then resume normal weekly schedule.
  • More than 5 days late: skip the missed dose, take your next scheduled dose, do not double up.
  • If you miss doses for β‰₯3 weeks: re-titration from the 0.25 mg starter dose is required.
  • Contact your prescriber if you miss 2 consecutive weekly doses.

Source: Wegovy FDA prescribing information (opens in a new tab)

People also ask

Common questions readers ask

Does Ozempic cause hair loss?
Not directly. Hair shedding (telogen effluvium) is reported by some patients ~3 months into rapid weight loss β€” typical of any rapid-weight-loss state, not unique to GLP-1.
Full evidence-graded answer
Can you drink alcohol on Wegovy?
No hard contraindication, but alcohol tolerance often drops sharply on GLP-1. Many patients also report reduced desire for alcohol β€” likely a secondary effect of GLP-1 on the brain reward system.
Full evidence-graded answer
Can I take GLP-1 while pregnant?
No. All FDA-approved GLP-1s carry a pregnancy contraindication. Stop GLP-1 at least 2 months before planned conception due to its long half-life.
Full evidence-graded answer
How much does Wegovy cost without insurance?
List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone).
Full evidence-graded answer
Is it safe to take GLP-1 long-term?
Liraglutide has 15+ years of post-marketing data (Victoza approved 2010). Semaglutide has 8+ years (Ozempic approved 2017). No new class-wide safety signals have emerged in extended follow-up. Chronic use is the FDA-approved indication for both T2D and obesity.
Full evidence-graded answer

Next step

See the full Wegovy drug profile β€” efficacy, side effects, cost, and provider options.

See full Wegovy profile

Editorial information based on FDA prescribing data. Not personal medical advice. For urgent symptoms call your prescriber or 911.